EUVIMEDEUVIMED entdecken
Crossref

Novel role of the SOX4/CSNK2A1 axis in regulating TOP2A phosphorylation in breast cancer progression

Jiaqiong Zou iD, Ruiman Geng iD, Zhengkun Zhang iD, Xuxu Ji iD, Zhaoru Yin iD, Dingxue Wang iD, Rong Guo iD, Lihong Chen iD, Ji Liu iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202401907rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Jiaqiong Zou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Biology, West China School of Basic Sciences & Forensic Medicine, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Breast Neoplasms, DNA Topoisomerases, Type II, SOXC Transcription Factors, Casein Kinase II. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examines the critical role of DNA topoisomerase II alpha (TOP2A) phosphorylation in breast cancer progression, regulated by the SRY‐box transcription factor 4 (SOX4)/Casein kinase II subunit alpha 1 (CSNK2A1) axis. Using integrated transcriptomic and proteomic analyses, data were sourced from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and The Cancer Genome Atlas (TCGA) databases. To explore the dataset, differential analysis, kinase‐substrate enrichment analysis (KSEA), and weighted gene co‐expression network analysis (WGCNA) were performed. Immune profiling, combined with survival analysis, revealed the prognosis linked to different immune profiles in breast cancer patients. In vitro experiments assessed the effect of SOX4 on CSNK2A1 promoter activity through real‐time quantitative polymerase chain reaction (RT‐qPCR), Western blot, dual‐luciferase reporter assays, and chromatin immunoprecipitation (ChIP). The phosphorylation level of TOP2A was also measured. Cell proliferation, migration, and invasion were evaluated using cell counting kit‐8 (CCK‐8), colony formation, and Transwell assays. In vivo studies extended to mouse models, where the effect of SOX4 on CSNK2A1‐TOP2A phosphorylation was analyzed about tumor growth and metastasis. The results showed that upregulation of SOX4 increases CSNK2A1 transcription, which in turn promotes TOP2A phosphorylation and accelerates breast cancer progression. The clinical analysis identified three immune profiles, with the intermediate profile associated with a poorer prognosis, possibly due to enhanced TOP2A phosphorylation mediated by SOX4/CSNK2A1. Silencing SOX4 significantly reduced cell proliferation, migration, invasion, and tumor growth in vivo by lowering CSNK2A1‐TOP2A phosphorylation. These findings highlight the therapeutic potential of targeting the SOX4/CSNK2A1 axis in breast cancer and provide insight into its mechanism through TOP2A phosphorylation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDNA Topoisomerases, Type IISOXC Transcription FactorsCasein Kinase IIPoly-ADP-Ribose Binding ProteinsHumansPhosphorylationFemaleAnimalsMiceDisease ProgressionCell ProliferationGene Expression Regulation, NeoplasticCell MovementCell Line, TumorMice, Nude

Stichwörter der Autor:innen

CSNK2A1 kinaseSOX4TOP2A phosphorylationbreast cancerproteomicstranscriptomicstumor growth and metastasis

Substanzen

DNA Topoisomerases, Type IISOXC Transcription FactorsTOP2A protein, humanCasein Kinase IISOX4 protein, humanPoly-ADP-Ribose Binding ProteinsCSNK2A1 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry & Molecular Biology, West China School of Basic Sciences & Forensic Medicine, Sichuan University, Chengdu, China.
  • West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Jiaqiong Zou, Ruiman Geng, Zhengkun Zhang, Xuxu Ji, Zhaoru Yin, Dingxue Wang, Rong Guo, Lihong Chen, Ji Liu

Zitieren

APA

Zou, J., Geng, R., Zhang, Z., Ji, X., Yin, Z., Wang, D., Guo, R., Chen, L., & Liu, J. (2025). Novel role of the SOX4/CSNK2A1 axis in regulating TOP2A phosphorylation in breast cancer progression. The FASEB Journal. https://doi.org/10.1096/fj.202401907rr

Vancouver

Zou J, Geng R, Zhang Z, Ji X, Yin Z, Wang D, et al. Novel role of the SOX4/CSNK2A1 axis in regulating TOP2A phosphorylation in breast cancer progression. The FASEB Journal. 2025. doi:10.1096/fj.202401907rr

BibTeX
@article{Zou2025,
  author = {Zou, Jiaqiong and Geng, Ruiman and Zhang, Zhengkun and Ji, Xuxu and Yin, Zhaoru and Wang, Dingxue and Guo, Rong and Chen, Lihong and Liu, Ji},
  title = {Novel role of the SOX4/CSNK2A1 axis in regulating TOP2A phosphorylation in breast cancer progression},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202401907rr}
}
Kostenlos starten →